1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 14 SEPTEMBER 2015

CNS Drug News 14 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Phase III Aducanumab Trial Is High Risk But High Reward
Industry Brief - Acadia Seeks Priority FDA Approval For Nuplazid In PDP
Industry Brief - Alvogen Launches First Generic Rivastigmine Patch In US
Industry Brief - FDA Places Encenicline Studies On Clinical Hold
Industry Brief - Amgen/Novartis Enter Neuroscience Collaboration
Industry Trend Analysis - RPI-78M Orphan Status Will Spur Development
Industry Brief - Mylan Gains Inter Partes Review Proceeding Against Third Glatiramer Patent
Industry Brief - First Advanced ALS Patient Enrolled In Phase II NIV Trial
Industry Brief - Evotec/CHDI Expand Ongoing Collaboration For Huntington's Disease
Industry Brief - Cerecor Initiates Phase II Study For CERC-301
Industry Brief - Lupin Launches New Duloxetine Strength
Industry Brief - FDA Advisory Committees Unanimously Recommend Xtampza ER Approval
Industry Brief - Oxaydo Launched In US
Industry Brief - Trevena Reports Positive Results From TRV130 Phase IIb Study In Acute Postoperative Pain
Industry Brief - ARX-04 Phase III Study Significantly Reduces Acute Pain
Industry Brief - Cara Initiates CR845 Phase III Programme
Industry Trend Analysis - Probuphine Represents A Unique Solution To Opioid Addiction
Industry Brief - FDA Accepts Fycompa NDA For Partial Onset/PGTC Seizures
Industry Trend Analysis - Innovative And Generic Approach To Vigabatrin Will Secure Niche Dominance
Industry Trend Analysis - Tesaro's First Drug Faces Battle For Position In Congested CINV Market
Industry Brief - FDA Approves Paediatric Indication For Emend
Industry Brief - Akynzeo Launched In UK
Industry Trend Analysis - Digital Medicine To Tackle Medication Adherence
Industry Brief - HLS Acquires US/Canadian Rights To Clozaril
Industry Brief - Horizon Commences Unsolicited Exchange Offer To Acquire Depomed
Industry Brief - PsychoGenics/Sunovion Extend Drug Discovery Collaboration
Industry Brief - Mundipharma/MVP Enter European Penthrox Deal
Industry Brief - Allergan Settles Namenda XR Patent Litigation With Amneal
Industry Brief - USPTO Dismisses Inter Partes Review Petition Of Tecfidera Patent
Industry Brief - Allergan Completes Naurex Acquisition
Industry Brief - Celgene Completes Receptos Acquisition
Industry Trend Analysis - Kremers Urban Acquisition To Double Lannett's Revenues
Industry Brief - Sun Acquires Opiates Business In Australia
Industry Brief - CogRx Completes Series B Financing
Industry Brief - CNS Conferences - December 2015

Table Of Contents

CNS Drug News 14 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.